Neurocytoma

A comprehensive review

Mehar Chand Sharma, Prabal Deb, Suash Sharma, Chitra Sarkar

Research output: Contribution to journalReview article

95 Citations (Scopus)

Abstract

Central neurocytomas (CN) are uncommon tumors of the central nervous system, most descriptions of which available in the literature are in the form of isolated case reports and small series. Owing to this rare incidence, diagnosis and management of this neoplasm remain controversial. Usually, these tumors affect lateral ventricles of young adults and display characteristic neuroimaging and histomorphologic findings. Neurocytomas often mimic oligodendrogliomas when confirmation of diagnosis rests on immunohistochemistry, ultrastructure, and genetic studies. Extraventricular neurocytomas, situated entirely within the brain parenchyma and spinal cord, have also been reported. Typically, CN are associated with a favorable outcome although cases with more aggressive clinical course with recurrences are not unknown. MIB-1 labeling index (LI) of >2% often heralds poor prognosis and tumour recurrence. Safe maximal resection is presently considered the ideal therapeutic option, with best long-term prognosis in terms of local control and survival. The role of adjuvant radiotherapy apparently seems to benefit patients with incomplete resection and in atypical neurocytoma. Utility of other therapeutic regimen, however, remains shrouded in controversy. Epidemiology, histogenesis, clinical profile, histology, neuroimaging and therapeutic modalities of neurocytomas have been comprehensively reviewed, with special emphasis on CN and extraventricular neurocytomas and their atypical counterparts.

Original languageEnglish (US)
Pages (from-to)270-285
Number of pages16
JournalNeurosurgical Review
Volume29
Issue number4
DOIs
StatePublished - Oct 1 2006
Externally publishedYes

Fingerprint

Neurocytoma
Neuroimaging
Oligodendroglioma
Recurrence
Central Nervous System Neoplasms
Neoplasms
Adjuvant Radiotherapy
Lateral Ventricles
Young Adult
Spinal Cord
Histology
Epidemiology
Therapeutics
Immunohistochemistry

Keywords

  • Atypical neurocytoma
  • Central neurocytoma
  • Extraventricular neurocytoma
  • Histopathology
  • Immunohistochemistry
  • MIB-1 LI
  • Recurrence
  • Therapy

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Neurocytoma : A comprehensive review. / Sharma, Mehar Chand; Deb, Prabal; Sharma, Suash; Sarkar, Chitra.

In: Neurosurgical Review, Vol. 29, No. 4, 01.10.2006, p. 270-285.

Research output: Contribution to journalReview article

Sharma, MC, Deb, P, Sharma, S & Sarkar, C 2006, 'Neurocytoma: A comprehensive review', Neurosurgical Review, vol. 29, no. 4, pp. 270-285. https://doi.org/10.1007/s10143-006-0030-z
Sharma, Mehar Chand ; Deb, Prabal ; Sharma, Suash ; Sarkar, Chitra. / Neurocytoma : A comprehensive review. In: Neurosurgical Review. 2006 ; Vol. 29, No. 4. pp. 270-285.
@article{ccc360d67c2b47e4b1366a5b4dba608f,
title = "Neurocytoma: A comprehensive review",
abstract = "Central neurocytomas (CN) are uncommon tumors of the central nervous system, most descriptions of which available in the literature are in the form of isolated case reports and small series. Owing to this rare incidence, diagnosis and management of this neoplasm remain controversial. Usually, these tumors affect lateral ventricles of young adults and display characteristic neuroimaging and histomorphologic findings. Neurocytomas often mimic oligodendrogliomas when confirmation of diagnosis rests on immunohistochemistry, ultrastructure, and genetic studies. Extraventricular neurocytomas, situated entirely within the brain parenchyma and spinal cord, have also been reported. Typically, CN are associated with a favorable outcome although cases with more aggressive clinical course with recurrences are not unknown. MIB-1 labeling index (LI) of >2{\%} often heralds poor prognosis and tumour recurrence. Safe maximal resection is presently considered the ideal therapeutic option, with best long-term prognosis in terms of local control and survival. The role of adjuvant radiotherapy apparently seems to benefit patients with incomplete resection and in atypical neurocytoma. Utility of other therapeutic regimen, however, remains shrouded in controversy. Epidemiology, histogenesis, clinical profile, histology, neuroimaging and therapeutic modalities of neurocytomas have been comprehensively reviewed, with special emphasis on CN and extraventricular neurocytomas and their atypical counterparts.",
keywords = "Atypical neurocytoma, Central neurocytoma, Extraventricular neurocytoma, Histopathology, Immunohistochemistry, MIB-1 LI, Recurrence, Therapy",
author = "Sharma, {Mehar Chand} and Prabal Deb and Suash Sharma and Chitra Sarkar",
year = "2006",
month = "10",
day = "1",
doi = "10.1007/s10143-006-0030-z",
language = "English (US)",
volume = "29",
pages = "270--285",
journal = "Neurosurgical Review",
issn = "0344-5607",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Neurocytoma

T2 - A comprehensive review

AU - Sharma, Mehar Chand

AU - Deb, Prabal

AU - Sharma, Suash

AU - Sarkar, Chitra

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Central neurocytomas (CN) are uncommon tumors of the central nervous system, most descriptions of which available in the literature are in the form of isolated case reports and small series. Owing to this rare incidence, diagnosis and management of this neoplasm remain controversial. Usually, these tumors affect lateral ventricles of young adults and display characteristic neuroimaging and histomorphologic findings. Neurocytomas often mimic oligodendrogliomas when confirmation of diagnosis rests on immunohistochemistry, ultrastructure, and genetic studies. Extraventricular neurocytomas, situated entirely within the brain parenchyma and spinal cord, have also been reported. Typically, CN are associated with a favorable outcome although cases with more aggressive clinical course with recurrences are not unknown. MIB-1 labeling index (LI) of >2% often heralds poor prognosis and tumour recurrence. Safe maximal resection is presently considered the ideal therapeutic option, with best long-term prognosis in terms of local control and survival. The role of adjuvant radiotherapy apparently seems to benefit patients with incomplete resection and in atypical neurocytoma. Utility of other therapeutic regimen, however, remains shrouded in controversy. Epidemiology, histogenesis, clinical profile, histology, neuroimaging and therapeutic modalities of neurocytomas have been comprehensively reviewed, with special emphasis on CN and extraventricular neurocytomas and their atypical counterparts.

AB - Central neurocytomas (CN) are uncommon tumors of the central nervous system, most descriptions of which available in the literature are in the form of isolated case reports and small series. Owing to this rare incidence, diagnosis and management of this neoplasm remain controversial. Usually, these tumors affect lateral ventricles of young adults and display characteristic neuroimaging and histomorphologic findings. Neurocytomas often mimic oligodendrogliomas when confirmation of diagnosis rests on immunohistochemistry, ultrastructure, and genetic studies. Extraventricular neurocytomas, situated entirely within the brain parenchyma and spinal cord, have also been reported. Typically, CN are associated with a favorable outcome although cases with more aggressive clinical course with recurrences are not unknown. MIB-1 labeling index (LI) of >2% often heralds poor prognosis and tumour recurrence. Safe maximal resection is presently considered the ideal therapeutic option, with best long-term prognosis in terms of local control and survival. The role of adjuvant radiotherapy apparently seems to benefit patients with incomplete resection and in atypical neurocytoma. Utility of other therapeutic regimen, however, remains shrouded in controversy. Epidemiology, histogenesis, clinical profile, histology, neuroimaging and therapeutic modalities of neurocytomas have been comprehensively reviewed, with special emphasis on CN and extraventricular neurocytomas and their atypical counterparts.

KW - Atypical neurocytoma

KW - Central neurocytoma

KW - Extraventricular neurocytoma

KW - Histopathology

KW - Immunohistochemistry

KW - MIB-1 LI

KW - Recurrence

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33748606130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748606130&partnerID=8YFLogxK

U2 - 10.1007/s10143-006-0030-z

DO - 10.1007/s10143-006-0030-z

M3 - Review article

VL - 29

SP - 270

EP - 285

JO - Neurosurgical Review

JF - Neurosurgical Review

SN - 0344-5607

IS - 4

ER -